ScoutQuest22 Oct 2026
Senores Pharmaceuticals544319Board meeting scheduled

Board meeting on October 29, 2026 to approve Q2 and H1 results

Senores Pharmaceuticals has called a Board meeting on Thursday, October 29, 2026.

By ScoutQuest · · 1 min read

Board Meeting Date
Thursday, October 29, 2026
Agenda Period
quarter and half year ended September 30, 2026
Trading Window Closure Start
October 01, 2026 till 48 hours after the results are approved

What was announced

The company has informed BSE (Scrip Code 544319) and NSE (Symbol SENORES) that a meeting of its Board of Directors is scheduled to be held on Thursday, October 29, 2026.

What the board will take up

Consolidated and Standalone, in simple words

Trading window

Referring to its earlier intimation dated September 24, 2026, the company said the trading window for dealing in its securities, for persons specified under its Code of Conduct (framed under SEBI's insider trading regulations), was closed from October 01, 2026 and will remain closed till 48 hours after the results are approved by the Board and submitted to the stock exchanges.

This is a restriction on designated persons covered by the Code; it is not a restriction on the company's shares being traded on the exchanges.

What to watch

The announcement is a scheduling intimation, so it sets a date rather than reporting performance.

More numbers
  • Trading window opens 48 hours after results are approved48 hours
Source: BSE · 22 Oct 2026

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.

About ScoutQuest · Logos provided by Logo.dev